Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres

References

• RW Ashford, J Seaman, J Schorscheer, and F Pratlong. (1992). Epidemic visceral Leishmaniasis in southern Sudan: Identity and systemic position of the parasites from patients and vectors. Trans R Soc Trop Med Hyg 86:379–380.
   PubMed Web of Science ®Google Scholar
• AJ Atkinson, and JE Bennett. (1978). Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother 13:271–276.
   PubMed Web of Science ®Google Scholar
• J Alvar, C Canarate, B Gutierrez-Solar, M Jimenez, F Laguma, R Lopez-Velez, R Molina, and J Moreno. (1997). Leishmania and human immunodeficiency virus coinfection-the first 10 years. Clin Microbial Rev 10:298–319.
   PubMed Web of Science ®Google Scholar
• GG Baily, and A Nandy. (1994). Visceral Leishmaniasis is more prevalent and more problematic. J Infect 29:241–247.
   PubMed Web of Science ®Google Scholar
• M Boelaert, B Criel, J Leeuwenburg, W Van Damme, D Le Ray, and P Van der Stuyft. (2000). Visceral Leishmaniasis control: A public health perspective. Trans R Soc Trop Med Hyg 94:465–471.
   PubMed Web of Science ®Google Scholar
• G Banerjee, G Nandi, SB Mahato, A Pakrashi, and MK Basu. (1996). Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes. J Antimocrob Chem 38:145–150.
   PubMed Web of Science ®Google Scholar
• SL Croft, RN Davidson, and EA Thornton. (1999). Liposomal amphotericin B in the treatment of visceral Leishmaniasis. J Antimicrob Agents 28(B):111–118.
   Google Scholar
• TK Daneshmend, and DW Warnock. (1983). Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 8:17–42.
   PubMed Web of Science ®Google Scholar
• EL Dorea, L Yu, I DaCastrol, SB Campos, M Ori, and EMH Vaccari. (1997). Nephrotoxicity of amphotericin B is attenuated by solubilizing with lipid emulsion. J Am Soc Nephrol 8:1415–1422.
   PubMed Web of Science ®Google Scholar
• I Echevarria, B Celia, JR Maria, and CDV Maria. (2000). High-performance liquid chromatographic determinations of amphotericin B in plasma and tissue: Application to pharmacokinetic and tissue distribution studies in rats. J Chromatogr A 819:171–176.
   Web of Science ®Google Scholar
• MS Espuelas, P Legrand, JM Irache, C Gamazo, AM Orecchioni, JP Devissaguet, and P Ygartua. (1997). Poly (ε-caprolactone) nanospheres as an alternative way to reduce amphotericin b toxicity. Int J Pharm 158:19–27.
   Web of Science ®Google Scholar
• HA Gallis, RH Drew, and WW Pickard. (1990). Amphotericin B: 30 years of clinical experience. Rev infect Dis 12:308.
   PubMedGoogle Scholar
• P Ghosh, and BK Bachhawat. (1980). Grafting of different glycosides on the surface of liposome and its effect on the tissue distribution of 125I-labelled gamma-globulin encapsulated in liposomes. Biochim Biophys Acta 632:562–572.
   PubMed Web of Science ®Google Scholar
• TM Gopper, and RH Muller. (2003). Plasma protein adsorption of Tween 80 and poloxamer 188-stabilized solid lipid nanoparticles. J Drug Target 11:225–231.
   PubMed Web of Science ®Google Scholar
• M Hultin, C Carneheim, K Rosenqvist, and T Olivercrona. (1995). Intravenous lipid emulsions: Removal mechanisms as compared to chylomicrons. J Lipid Res 36:2174–2184.
   PubMed Web of Science ®Google Scholar
• RK Jain. (1994). Barriers to drug delivery in solid tumors. Sci Am 271:58–65.
   PubMed Web of Science ®Google Scholar
• SH Khoo, J Bond, and DW Denning. (1994). Administering amphotericin B- A practical. J Antimicrob Chemother 33:213.
   Google Scholar
• A Kimura, H Yamaguchi, K Watanabe, M Hayashi, and S Awazu. (1986). Factors influencing the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: Emulsifying agents and lipoprotein lipase activity. J Pharm Pharmacol 38:659–662.
   PubMed Web of Science ®Google Scholar
• J Kreuter, RN Alyantdin, D Kharkevich, and AA Ivanov. (1995). Passage of peptides through the blood brain with colloidal polymer particles (nanoparticles). Brain Res 674:171–174.
   PubMed Web of Science ®Google Scholar
• A Kurihara, T Shibayama, A Mizota, A Yasuno, M Ikeda, K Sasugawa, T Kobayashi, and M Hisaoka. (1996a). Lipid emulsions of palmitoylrhizoxin: Effects of composition on lipolysis and biodistribution. Biopharm Drug Dispos 17:331–342.
   PubMed Web of Science ®Google Scholar
• A Kurihara, T Shibayama, A Yasuno, M Ikeda, and M Hisaoka. (1996b). Lipid emulsions of palmitoylrhizoxin: Effects of particle size on blood dispositions of emulsion lipid and incorporated compounds in rats. Biopharm Drug Dispos 17:343–353.
   PubMed Web of Science ®Google Scholar
• KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ON Srivastava, and S Sunder. (2008). Antileishmanial activity of nano-amphotericin B deoxycholate. J Antimicrob Chemother 62 (2):376–380.
   PubMed Web of Science ®Google Scholar
• K Moribe, and M Watsura. (1998). Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives. Pharm Res 15:1737–1742.
   PubMed Web of Science ®Google Scholar
• J Senior, C Delgado, D Fisher, C Tilcock, and G Gregoriadis. (1991). Influence of surface hydrophilicity of liposome on their interpretation with plasma-protein and clearance from the circulation studies with poly (ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062:77–82.
   PubMed Web of Science ®Google Scholar
• V Schreoder, P Sommerfield, S Ulrich, and BA Sabel. (1998). Nanopartricle technology for delivery of drug across the blood brain barrier. J Pharm Sci 87:1305–1307.
   PubMed Web of Science ®Google Scholar
• JJ Shaw. (1994). Taxonomy of the genus leishmania: Present and future trends and their implications. Mem Inst Oswaldo Cruz 89:471–478.
   PubMed Web of Science ®Google Scholar
• LA Stauber, EM Franchino, and J Grun. (1958). An eight day method for screening compounds against Leishmania donovani in the golden hamster. J Protozool 5:269–273.
   Google Scholar
• A Surolia, A Ahmad, and BK Bachhawat. (1975). Affinity chromatography of galactose containing bio-polymers using co-valently coupled ricinus-communis lectin to sepharose-4B. Biochim Biophys Acta 404:83–92.
   PubMed Web of Science ®Google Scholar
• T Takino, K Konishi, Y Takakura, and M Hashida. (1994). Long circulating emulsion carrier system for highly lipophilic drugs. Biol Pharm Bull 17:121–125.
   PubMed Web of Science ®Google Scholar
• T Takino, C Nakajima, Y Takakura, H Sezaki, and M Hashida. (1993). Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J Drug Target 1:117–124.
   PubMed Web of Science ®Google Scholar
• D Tuhina, A Khairul, A Farhat, and A Nahid. (2000). Antileishmanial activities of stearylamine liposomes. Antimicrob Agents Chemother 44:1739–1742.
   PubMed Web of Science ®Google Scholar